Kaya Holdings (KAYS) Retained Earnings (2011 - 2025)
Kaya Holdings (KAYS) recorded quarterly Retained Earnings of -$9845.0 in Q3 2025, up 99.98% quarter-over-quarter from -$42.7 million in Q2 2025, and up 99.98% on a YoY basis from -$4923.1 in Q3 2024.
Kaya Holdings (KAYS) Retained Earnings (2011 - 2025) Analysis & Trends
Kaya Holdings' Retained Earnings history runs 15 years deep, the most recent figure standing at -$9845.0 for Q3 2025.
- In Q3 2025, Retained Earnings rose 99.98% year-over-year to -$9845.0; the TTM figure through Sep 2025 stood at -$9845.0 (up 99.98% YoY), while the FY2024 annual figure was -$15571.0, down 23.41% from the prior year.
- Retained Earnings was -$9845.0 for Q3 2025 at Kaya Holdings, up from -$42.7 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$2966.0 in Q3 2021 to a low of -$49.7 million in Q1 2021.
- Historically, Retained Earnings has averaged -$15.2 million across 5 years, with a median of -$13614.0 in 2024.
- The sharpest annual moves came in 2021 and 2023: Retained Earnings soared 99.99% in 2021, then sank 659018.99% in 2023.
- A 5-year view of Retained Earnings shows it stood at -$3719.0 in 2021, then slumped by 196.5% to -$11027.0 in 2022, then dropped by 14.42% to -$12617.0 in 2023, then dropped by 23.41% to -$15571.0 in 2024, then jumped by 36.77% to -$9845.0 in 2025.
- The last three Retained Earnings figures came in at -$9845.0 (Q3 2025), -$42.7 million (Q2 2025), and -$40.2 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -4.41 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -1.87 Mn |
| 10 | Kaya Holdings | - | - | 5,370.00 | -9,845.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -9,845.00 |
| Jun 30, 2025 | -42.66 Mn |
| Mar 31, 2025 | -40.18 Mn |
| Dec 31, 2024 | -15,571.00 |
| Sep 30, 2024 | -39.60 Mn |
| Jun 30, 2024 | -37.14 Mn |
| Mar 31, 2024 | -13,614.00 |
| Dec 31, 2023 | -12,617.00 |
| Sep 30, 2023 | -14,538.00 |
| Jun 30, 2023 | -12,529.00 |
| Mar 31, 2023 | -38.00 Mn |
| Dec 31, 2022 | -11,027.00 |
| Sep 30, 2022 | -12,900.00 |
| Jun 30, 2022 | -9,688.00 |
| Mar 31, 2022 | -5,766.00 |
| Dec 31, 2021 | -3,719.00 |
| Sep 30, 2021 | -2,966.00 |
| Jun 30, 2021 | -40.56 Mn |
| Mar 31, 2021 | -49.74 Mn |
| Dec 31, 2020 | -44.22 Mn |